pharmaceutical investing Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results
pharmaceutical investing Zogenix Announces Receipt of FDA Breakthrough Therapy Designation for ZX008 in Dravet Syndrome
Pinnacle Silver and Gold Corp. Announces Participation in THE Mining Investment Event, Quebec City, June 3-5, 2025